chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 65-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 15-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported No Treatment medications were reported
Fast heartbeat; Anxiety; Nervousness; Stomach pain; Problems with his eyesight; Like stomach reactions like he is going to vomit but doesn't end up vomiting; Malaise; Headache; Fever; going to vomit but doesn't end up vomiting; This is a spontaneous report from a contactable consumer or other non-healthcare professional (patient's father). A 21-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in left arm on 07Jun2021 (21-year-old at the time of vaccination) as dose 2, single for covid-19 immunization. Medical history included not reported. The concomitant medications were none. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date on 2021 as dose 1, single for covid-19 immunization. On an unspecified date on 2021, the patient presented symptoms he had never had such as, fast heartbeat, malaise, anxiety, nervousness, headache, stomach pain, problems with his eyesight and fever. The patient had to be admitted into the emergency room, had several studies done and no abnormalities were diagnosed. The reporter stated that Pfizer covid vaccine on 07Jun2021. After the vaccine the patient had a fast heartbeat, general malaise, felt nervous, headache, a stomach-ache, and a fever. The patient had to go to the emergency room, and they performed tests and analysis on him and nothing came up. This event started about a week after the vaccine and his heart rate was speeding up. The heart rate and anxiety and headaches and like stomach reactions like he is going to vomit but doesn't end up vomiting. The symptoms are different on different days. The heart rate only happened once and everything has continued to happen. This happened after the second dose of the vaccine. They sent the patient from the emergency room to another place and admitted him for 2 days. The reporter is unsure of the dates of admission. They sent the patient to a hospital where there was a cardiologist and the patient stayed there for 2 days. As Per fact sheet, what are the risks of the Pfizer BioNTech covid-19 vaccine, revised: 25Jun2021, fast heartbeat is listed as one of the signs of a possible severe allergic reaction. Most of these side effects don´t have a mean duration documented, some of the side effects have a range of appearance from 1-36 days. The reporter asked for treatment recommendations for patient. The events were serious - hospitalization. The outcome for the event's fast heartbeat, visual impairment, abdominal discomfort, pyrexia, going to vomit but doesn't end up vomiting were unknown and other events were not resolved.  Information about batch/lot number has been requested.
"22, 23, & 24MAY temp (a) of  100 given APAP;25, 26, 27MAY rash began on back to chest to neck & face;gone by 28MAY;poor appetite 22-26MAY;1 episode n& v 22MAY;"
Patient reported many cyst like bumps on her left arm 1 week after second dose of shingrix administration. No previous issues or other adverse reactions from first dose.
7 hours after vaccine I experienced flu like symptoms: fever, chills, body aches, headache, extreme fatigue.
After administration of the flu vaccine, my heart rate escalated into the 130s within 5-7 minutes.  I was very short of breath and my throat felt as if it was "closing off". An IV was started at the clinic and Benadryl 50mg IM was given, O2 per mask was given, all without relief of symptoms. 911 was called and the paramedic took me to the local hospital with an EKG reading of sinus tachycardia 150-160s.  I had uncontrollable shaking and trembling throughout the entire time.  I was given additional Benadryl 50mg IV, Solumedrol, Albuterol treatment and Ativan 2mg at the hospital where I remained on the heart monitor for 4 hours with heart rate remaining in the 140s.  Was discharged after my heart rate dropped to 91.
Pt vaccinated with DTP/OPV/HIB Titer found blue in crib.
I waited 15 minutes after I had the vaccine, and I was fine. Around 930PM I was feeling bad arm was sore and hurting so I went on to bed. I woke up I had nausea spells and felt fatigued. I felt bad for the next two weeks. I was throwing up at work and was taking ibuprofen. I had swollen lymph nodes under my arm and back of my neck. My throat and side of jaw started swelling. I kept icing the swelling. I went and saw my doctor and he advised me to not take the Miloxacin. My MD ordered an EPI pen in case I needed it if I was having an allergic reaction. He advised to take Benadryl and Ibuprofen. I laid on my couch and around 930PM my ribs and throat started feeling restricted like I was suffocating. I ended up having to sleep sitting up because I couldn?t breathe. I talked to my MD Monday and he ordered oral steroids. I felt fine Tuesday and Wednesday and today I haven?t felt good. I have also been suffering with joint pain and a wheezing cough.
rash lt deltoid, lt axilla, lt scapula nape of neck;no itching;no pain;rash is warm to touch;tx w/DPH & cool compresses;
This spontaneous case reported by a consumer, describes the occurrence of neck pain and vaccination site swelling (swelling at injection site) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On May 11, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced neck pain and vaccination site swelling (swelling at injection site). At the time of the report, neck pain and vaccination site swelling (swelling at injection site) outcome: unknown. No concomitant medication or treatment information provided. Action taken with mRNA-1273 in response to the event: not applicable.
Patient presented 48 hr after immunization with 15x20cm area of erythema, warmth and swelling (L) leg -> site of PREVNAR injection.
plantiffs allege that as a result of vax child suffered an unspecified"severe and permanent reaction to the pertussis portion" of the vaccine.
After I got my 2nd vaccination, I did not get a period that month and did not get a period for the following 6 months. They call that secondary amenorrhea. No treatment. I went to the doctor, and they said it was more than likely the vaccination and said that there were lots of menstrual changes for people who have received their vaccine. But it came back and resolved itself.
Ever since getting the vaccine I've had terrible periods. Sometimes they are really late and sometimes really early. I can't get out of bed the first day or two of my period. I have a lot of pain. Pain in my neck and down my spine. Pain down my legs. Headaches. Trouble sleeping from discomfort. Overall achy. I've never had bad periods before the vaccine and now I've had 3 really bad periods.
Pt presents to clinic with c/o fever of 104 degrees, increase fussiness and unconsolable for past 12 hrs. Pt received vaccines the day before. Sites of injections non-reddened, non-swollen. Diagnosis: Pertussis reaction. Tx: Rocephin 1 gm given IM.
About 7-10 days after the Moderna booster shot I developed hives which traveled all over my body. They were so extreme that I had to take Benadryl to sleep at night, and then Zyrtec daily to get them under control. I saw my GP twice who also prescribed additional medicines and wanted me to eliminate foods to see if that helped. Instead, I went to see an allergist.
interactions with coumadin; INR increased; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team.  A female patient received pf-06928316 (ABRYSVO), as dose number unknown, single (Batch/Lot number: unknown) for immunisation; for immunisation; warfarin sodium (COUMADIN), (Batch/Lot number: unknown). The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INTERACTION (non-serious), outcome "unknown", described as "interactions with coumadin"; INTERNATIONAL NORMALISED RATIO INCREASED (non-serious), outcome "unknown", described as "INR increased". Relevant laboratory tests and procedures are available in the appropriate section. The action taken for warfarin sodium was unknown. Additional information: Patient was on coumadin and her INR was increased the week after receiving the vaccine. The reporter was asking if there any interactions with coumadin. Her dose has always been the same historically but he doesn't know the dose.  The information on the batch/lot number for pf-06928316, pf-06928316  has been requested and will be submitted if and when received.
Diarrhea; headache; muscle soreness; body aches; nasal congestion; fatigue; dry mouth; This is a spontaneous report from a contactable consumer (patient herself). A 42-year-old female patient received the first dose of BNT162B2, via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization.  The patient's illness at vaccine included asthma and took Breo inhaler on day of vaccine injection. Concomitant medication included fluticasone furoate, vilanterol trifenatate (BREO ELLIPTA) for asthma. The patient experienced diarrhea, headache, muscle soreness, body aches, nasal congestion, fatigue, and dry mouth on an unspecified date. Events took place after use of product. The  outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient got injection on 8/13.   On 8/14, he had flu like symptoms:  fatigue, achy.   On 8/15, he developed red rash on his back.  Rash most prevalent on back on each side next to both arms but it does extend to mid back and near buttocks.  He denied any pain or itchiness.  I recommended for him to watch it and could use hydrocortisone for inflammation or benadryl for  itch.  I also advised to call doctor if symptoms worsen or if it does not improve in 2 days.
Breastfeeding mother received vaccine; This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE VIA BREAST MILK (Breastfeeding mother received vaccine) in a  infant of an unknown age and gender exposed to mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) , while the mother received the product for COVID-19 vaccination.     No Medical History information was reported.    On 01-May-2021, the mother received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 01-May-2021, the infant was diagnosed with EXPOSURE VIA BREAST MILK (Breastfeeding mother received vaccine). At the time of the report, EXPOSURE VIA BREAST MILK (Breastfeeding mother received vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Transmammary) was unknown.       No concomitant medications reported.  No treatment information provided.
Pt recvd 2 doses of Engerix-B vax in JUN & JUL91 & found to have an elevation of SGPT on PE; repeat testing indicated SGPT, SGOT & GGT were elevated; all other nl; pt also exp rt upper quad pressures/pain & GI burning;
PATIENT RECEIVED A PFIZER COVID-19 VACCINE THAT WAS LEFT OUTSIDE OVER NIGHT PASSED THE 6 HOURS EXPIRATION DATE.  NO ADVERSE EFFECTS REPORTED
ErythemaMultiform, UrticariaPruritus, DEVELOPED URTICARIA, PRURITUS, ERYTHEMA MULTIFORM TO FACE, BILATERAL UPPER EXTREMITIES, BACK, & CHEST ~4 HOURS FOLLOWING INJECTION. PATIENT TOOK OTC BENADRYL 50MG, LORATADINE 20MG AND PEPCID 80MG AND SYMPTOMS IMPROVED GREATLY. NO RESPIRATORY SYMPTOMS.
Menactra was given on 1/31/08. Expiration of vaccine was 1/19/08; no adverse reaction
A report has been received from a Health Professional concerning a subject of unknown gender, who had been receiving Nasal FLUMIST Quadrivalent. FLUMIST Quadrivalent started on an unknown date. A nurse from called Medical information to seek further information on administering FLUMIST to child under 2 years of age. She had received a call that a physician administered FLUNMIST to a 20 months old child. The child had no adverse events. The outcome of the event of FLUMIST Quadrivalent administered to a child under 2 years of age and FLUMIST to a child under 2 years of age is unknown. The reporter's description of the event(s) was as follows: child healthy otherwise. The report was considered to be non-serious by reporter and company physician. The reporter considered that there was no casual relationship between FLUMIST administered  to a chld under 2 years of age and FLUMIST Quadrivalent.
Sensation kept spreading; bruise on right leg; Back of right arm has red rash; Swelling at site of injection; Pain in arm of injection; Tingling in right and left arm 30 minutes after injection; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling in right and left arm 30 minutes after injection), CONDITION AGGRAVATED (Sensation kept spreading), CONTUSION (bruise on right leg), RASH ERYTHEMATOUS (Back of right arm has red rash) and INJECTION SITE SWELLING (Swelling at site of injection) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy and Drug allergy (Motrin).    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced PARAESTHESIA (Tingling in right and left arm 30 minutes after injection), CONTUSION (bruise on right leg), RASH ERYTHEMATOUS (Back of right arm has red rash), INJECTION SITE SWELLING (Swelling at site of injection) and VACCINATION SITE PAIN (Pain in arm of injection). On 18-Mar-2021, the patient experienced CONDITION AGGRAVATED (Sensation kept spreading). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PARAESTHESIA (Tingling in right and left arm 30 minutes after injection), CONDITION AGGRAVATED (Sensation kept spreading), CONTUSION (bruise on right leg), RASH ERYTHEMATOUS (Back of right arm has red rash), INJECTION SITE SWELLING (Swelling at site of injection) and VACCINATION SITE PAIN (Pain in arm of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator
Information has been received from a pharmacist concerning her 22 year old daughter with CECLOR allergy who on 11-AUG-2008 was vaccinated with the first dose of GARDASIL. Concomitant therapy included hormonal contraceptives (unspecified). On 12-AUG-2008 the patient developed fever of 100 degrees F and headache. The patient's fever persisted and was still present at the time of the report. The headache was not a complaint at the time of the report. The patient was treated with acetaminophen. The patient did not seek medical attention. Additional information has been requested.
Started with stiff neck and headache at around 1pm on 8/19/21 aprix 4 to 5 hours after vaccination.  Headache becomes sever by 5pm. Fatigue, weak and fever that night. Woke from a nap due to checking on blood. Headache so sever and bloody nose and mouth. This about 12 hours after vaccination. I was so weak I couldn't get of the floor to get myself something to drink.  I missed work and had to call for help. I had to have someone monitor me to assure I could breath due to the swelling in my neck.  Swollen lymph knots in neck, armpit, abdomen and groin. Right arm sever weaknesses, swelling. Sweating from armpit that is sever just weeping almost. Gi upset on and off with no appetite. I was not able to return to work until day 5. I still have the one sided headaches with brain fog, body aches with weakness and right arm is still swelling with the armpit sweating several.  I have also had a trip to the ER due to abdomen pain and weakness.
seen in emergency room twenty-four hours after vaccines were administered with apenic spells and cyanotic episodes, along with fever.  7/7/09 Hospital records received DOS 5/5/09 5/9/09. Assessment: RSV bronchiolitis, Acute Febrile Illness. Patient presented with increased sleepiness, shortness of breath and difficulty breathing. Hypoxic, febrile. Nasal congestion. Rash on cheeks.  ICD-9 Codes: 466.11, 288.60, 780.60, 799.02
6/13/03 approx. 6 hrs after DTaP, Rt deltoid became inflamed (red area hot to touch) and swollen-mom's statement. 6/17/03 pt's RD swollen and sl. pink when pt came to the clinic. No Tx given.
Got chills, muscle aches, headache, hives on day shot administered. 12 days later started seeing defined red and purple splotches, started on hands and palms, spread over my entire body over the next 2 days.  Splotches were dark purple.  Went to clinic, they were unsure of the cause.  Waited a day and then went to another clinic where they thought it might be Coxsackievirus, except there were no sores in the mouth and the splotches were on the palms and pads of the feet.  The splotches faded over the next 2 weeks, the last place they were visible were on the upper arm,  torso and thighs.
Patient received Moderna dose 2 as opposed to Pfizer dose 2 inadverntantley.  No adverse effects noted, patient monitored for 45 minutes.
1413 client vaccinated with J&J. Within minutes client with diaphoresis, clammy, and pale. 1415 client experienced  loss of consciousness. Staff assisted client to wheel chair. V/S: bp-88/60, HR 76, SPO2 98%. EMS called. Client aroused by RN, client returned consciousness. Offered water and something to eat, client states hes only had M&M's today. V/S now BP 104/64, HR 74, SPO2 98%. client color has returned A/O x4, states he feels better.  EMS on scene @ 1420 client assessed and cleared. Client monitored and released from clinic at 1435, No s/s of distress noted.
This spontaneous report was received from an unknown reporter refers to a 16 year old female patient. The patient had concurrent condition of duplex kidney. The medical history and concomitant medications were not reported. On 02-NOV-2015 at 11:00 am, the patient was vaccinated with GARDASIL lot # L016428, dose 2 in the right arm for prophylaxis. On 02-NOV-2015, the patient felt dizzy after vaccination. The diagnostic tests and laboratory tests were none. Illness at the time of vaccination was none. The outcome of the event was reported as recovered/resolved. The causality was not reported. Additional information has been requested.
got first dose /on 10/20/2019 /came /today to get second dose.; This case was reported by a nurse via call center representative and described the occurrence of drug dose administration interval too long in a 80-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose (0.5 ml) on 20th October 2019, intramuscularly in unknown arm).   On 30th June 2021, the patient received the 2nd dose of Shingrix. On 30th June 2021, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional details were provided as follows: The nurse stated that, the patient came into the office at the time of reporting to get the second dose of Shingrix later than the recommended interval, which led to lengthening of the vaccine schedule. No further information was reported The reporter consented to follow up.
So, I initially it was a burning sensation on left shoulder, they did it too high and I currently have a tingling on my upper shoulder and my doctor wanted me to wait another week to see how things get and if things don't get any better, she wants me to get referral for a I will physical therapy.
rash on injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash on injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (rash on injection site). At the time of the report, VACCINATION SITE RASH (rash on injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided.    Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: TCR added. Patient hang up the call, not interested. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Mar-2021 and was forwarded to Moderna on 05-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash on injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (rash on injection site). At the time of the report, VACCINATION SITE RASH (rash on injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided.    Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: TCR added. Patient hang up the call, not interested.
Case number PHEH2015US026847, is a spontaneous report initially received from a nurse on 22 Dec 2015. This report refers to a 37 years old male patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1514501, expiry date: May 2016) into left deltoid on 06 Oct 2015 which was out of temperature range (34 degrees Celsius). The reporter stated that she did not know why the refrigerator was out of temperature range for an unspecified amount of time overnight. She checked the temperature before she left for the day and when she arrived the next day and the temperature was fine. It was a new refrigerator and there were not problems since the temperature excursion. No adverse event was reported following this medication error. Follow up information received via nurse on 26 Jan 2016: Reporter's comments updated.
Menopause started.  Left foot turned purple.  All my vital were and still are great.